Zai Lab Ltd — Director's Dealing 2022

Apr 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2022-04-01

Reporting Person: Liang Yi (CCO & President, Greater China)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-01	American Depositary Shares	M	730	$0.00	Acquired	104847	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-01	Stock Options (Right to Buy)	$45.47	A	37585	Acquired	2032-04-01	American Depositary Shares (37585)	Direct
2022-04-01	Restricted Share Units	$	A	7154	Acquired		American Depositary Shares (7154)	Direct
2022-04-01	Restricted Share Units	$	M	730	Disposed		American Depositary Shares (730)	Direct

Footnotes

F1: Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer.

F2: ADSs acquired on vesting of Restricted Share Units. Each ADS represents ten Ordinary Shares of the issuer.

F3: The Stock Options are exercisable for ADSs. The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer.

F4: The Stock Options vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant.

F5: Each Restricted Share Unit represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.

F6: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.

F7: The Restricted Share Units vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.